Which of the following are FDA-approved indications for hydroxyzine hydrochloride? Select all that apply.

A. Edema is typically managed with diuretic agents that inhibit sodium reabsorption in the renal tubules. Hydroxyzine is an H1-receptor antagonist and does not possess the pharmacological properties required to mobilize interstitial fluid. It is not an FDA-approved treatment for edema. B. Status asthmaticus is a life-threatening medical emergency requiring systemic corticosteroids and bronchodilators. Hydroxyzine is contraindicated in early pregnancy and not indicated for acute respiratory distress. It lacks the beta-2 adrenergic agonist activity necessary to reverse severe bronchospasm in asthma. C. Pruritus due to histamine-mediated reactions is a primary FDA-approved indication for hydroxyzine. As a first-generation antihistamine, it competitively blocks H1 receptors to alleviate itching associated with dermatological conditions. It is specifically indicated for allergic conditions such as chronic urticaria. D. Anxiety is an FDA-approved labeled indication for hydroxyzine hydrochloride. It exerts anxiolytic effects by acting as an antagonist at the 5-HT2A serotonin receptor and H1 receptors in the central nervous system. This results in significant sedative and calming properties.